Towards the standardization of stem cell therapy studies for ischemic heart diseases: Bridging the gap between animal models and the clinical setting.

[1]  Tatsuya Shimizu,et al.  Myoblast cell sheet transplantation enhances the endogenous regenerative abilities of infant hearts in rats with myocardial infarction , 2017, Journal of tissue engineering and regenerative medicine.

[2]  J. Werneck-de-Castro,et al.  Sustained IGF-1 Secretion by Adipose-Derived Stem Cells Improves Infarcted Heart Function , 2016, Cell transplantation.

[3]  D. Mcfadden,et al.  Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium. , 2015, International journal of cardiology.

[4]  M. Yen,et al.  Human Placenta-Derived Multipotent Cells (hPDMCs) Modulate Cardiac Injury: From Bench to Small and Large Animal Myocardial Ischemia Studies , 2015, Cell transplantation.

[5]  P. Pattany,et al.  Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy. , 2015, Journal of the American College of Cardiology.

[6]  S. Sano,et al.  Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial. , 2015, The Journal of thoracic and cardiovascular surgery.

[7]  P. Menasché.  Stem cells for the treatment of heart failure , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[8]  S. Richard,et al.  Stimulating endogenous cardiac repair , 2015, Front. Cell Dev. Biol..

[9]  J. Kastrup,et al.  A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial , 2015, European heart journal.

[10]  P. Doevendans,et al.  Autologous Mesenchymal Stem Cells Show More Benefit on Systolic Function Compared to Bone Marrow Mononuclear Cells in a Porcine Model of Chronic Myocardial Infarction , 2015, Journal of Cardiovascular Translational Research.

[11]  M. Cowie,et al.  Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial , 2015, European heart journal.

[12]  A. Hagège,et al.  Long-term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  Amit N. Patel,et al.  REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure , 2015, Stem cells translational medicine.

[14]  D. Stewart,et al.  Paracrine Engineering of Human Cardiac Stem Cells With Insulin-Like Growth Factor 1 Enhances Myocardial Repair , 2015, Journal of the American Heart Association.

[15]  Qiang Zhao,et al.  Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction. , 2015, Biomaterials.

[16]  Alessandro Giacomello,et al.  Epicardial application of cardiac progenitor cells in a 3D-printed gelatin/hyaluronic acid patch preserves cardiac function after myocardial infarction. , 2015, Biomaterials.

[17]  Mark A Sussman,et al.  Cardiac Stem Cell Hybrids Enhance Myocardial Repair. , 2015, Circulation research.

[18]  T. Okano,et al.  Xenotransplantation of Bone Marrow-Derived Human Mesenchymal Stem Cell Sheets Attenuates Left Ventricular Remodeling in a Porcine Ischemic Cardiomyopathy Model. , 2015, Tissue engineering. Part A.

[19]  W. Fang,et al.  Dual isotope simultaneous imaging to evaluate the effects of intracoronary bone marrow-derived mesenchymal stem cells on perfusion and metabolism in canines with acute myocardial infarction. , 2015, Biomedical reports.

[20]  C. Gálvez-Montón,et al.  Tissue Engineering and Regenerative Medicine Postinfarction Functional RecoveryDrivenbyaThree- Dimensional Engineered Fibrin Patch Composed of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells , 2015 .

[21]  S. Wu,et al.  Intramuscular Transplantation of Pig Amniotic Fluid-Derived Progenitor Cells Has Therapeutic Potential in a Mouse Model of Myocardial Infarction , 2015, Cell transplantation.

[22]  S. Dhingra,et al.  Stem cell therapy for cardiac regeneration: hits and misses. , 2015, Canadian journal of physiology and pharmacology.

[23]  G. Angelini,et al.  Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair. , 2015, Circulation research.

[24]  Yu Liu,et al.  Bcl-xL Genetic Modification Enhanced the Therapeutic Efficacy of Mesenchymal Stem Cell Transplantation in the Treatment of Heart Infarction , 2015, Stem cells international.

[25]  Kaytlyn A. Gerbin,et al.  The winding road to regenerating the human heart. , 2015, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[26]  Timothy J. Nelson,et al.  Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy , 2015, Journal of the American Heart Association.

[27]  J. Olgin,et al.  Immuno-modification of enhancing stem cells targeting for myocardial repair , 2015, Journal of cellular and molecular medicine.

[28]  A. Haverich,et al.  Transplantation Effectiveness of Induced Pluripotent Stem Cells Is Improved by a Fibrinogen Biomatrix in an Experimental Model of Ischemic Heart Failure. , 2015, Tissue engineering. Part A.

[29]  G. Spinetti,et al.  Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction , 2015, Stem Cell Research & Therapy.

[30]  E. Mervaala,et al.  Comparison of Arrhythmogenicity and Proinflammatory Activity Induced by Intramyocardial or Epicardial Myoblast Sheet Delivery in a Rat Model of Ischemic Heart Failure , 2015, PloS one.

[31]  B. Riegel,et al.  Racial Differences in Clinical Treatment and Self‐Care Behaviors of Adults With Chronic Heart Failure , 2015, Journal of the American Heart Association.

[32]  Timothy J. Nelson,et al.  Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload , 2015, Stem Cell Research & Therapy.

[33]  Xiujuan Li,et al.  Ghrelin Improves Functional Survival of Engrafted Adipose-Derived Mesenchymal Stem Cells in Ischemic Heart through PI3K/Akt Signaling Pathway , 2015, BioMed research international.

[34]  M. Pucéat,et al.  Right ventricular failure secondary to chronic overload in congenital heart diseases: benefits of cell therapy using human embryonic stem cell-derived cardiac progenitors. , 2015, The Journal of thoracic and cardiovascular surgery.

[35]  Lianbo Yu,et al.  MicroRNA-133a Engineered Mesenchymal Stem Cells Augment Cardiac Function and Cell Survival in the Infarct Heart , 2015, Journal of cardiovascular pharmacology.

[36]  P. Hsieh,et al.  Human Placenta‐Derived Adherent Cells Improve Cardiac Performance in Mice With Chronic Heart Failure , 2015, Stem cells translational medicine.

[37]  J. García-Verdugo,et al.  Neuregulin-1β induces mature ventricular cardiac differentiation from induced pluripotent stem cells contributing to cardiac tissue repair. , 2015, Stem cells and development.

[38]  Shuhei Sato,et al.  Intracoronary Autologous Cardiac Progenitor Cell Transfer in Patients With Hypoplastic Left Heart Syndrome: The TICAP Prospective Phase 1 Controlled Trial , 2015, Circulation research.

[39]  V. Glinkina,et al.  Bone Marrow-Derived Multipotent Stromal Cells Promote Myocardial Fibrosis and Reverse Remodeling of the Left Ventricle , 2015, Stem cells international.

[40]  M. Olandoski,et al.  Direct intracardiac injection of umbilical cord-derived stromal cells and umbilical cord blood-derived endothelial cells for the treatment of ischemic cardiomyopathy , 2015, Experimental biology and medicine.

[41]  Kai-Wei Chang,et al.  Loss of non-coding RNA expression from the DLK1-DIO3 imprinted locus correlates with reduced neural differentiation potential in human embryonic stem cell lines , 2015, Stem Cell Research & Therapy.

[42]  Bor Luen Tang,et al.  SIRT7 and hepatic lipid metabolism , 2015, Front. Cell Dev. Bio..

[43]  M. Kyba,et al.  Derivation and High Engraftment of Patient-Specific Cardiomyocyte Sheet Using Induced Pluripotent Stem Cells Generated From Adult Cardiac Fibroblast , 2015, Circulation. Heart failure.

[44]  I. Komuro,et al.  Anti‐Inflammatory Peptides From Cardiac Progenitors Ameliorate Dysfunction After Myocardial Infarction , 2014, Journal of the American Heart Association.

[45]  Y. Yoon,et al.  Cultured human bone marrow-derived CD31(+) cells are effective for cardiac and vascular repair through enhanced angiogenic, adhesion, and anti-inflammatory effects. , 2014, Journal of the American College of Cardiology.

[46]  G. Pasterkamp,et al.  Intracoronary Infusion of Encapsulated Glucagon-Like Peptide-1–Eluting Mesenchymal Stem Cells Preserves Left Ventricular Function in a Porcine Model of Acute Myocardial Infarction , 2014, Circulation. Cardiovascular interventions.

[47]  Ling Wei,et al.  Preconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of rats , 2014, Stem Cell Research & Therapy.

[48]  Y. Yoon,et al.  Cell Therapy with Embryonic Stem Cell-Derived Cardiomyocytes Encapsulated in Injectable Nanomatrix Gel Enhances Cell Engraftment and Promotes Cardiac Repair , 2014, ACS nano.

[49]  Joseph C. Wu,et al.  Cross Talk of Combined Gene and Cell Therapy in Ischemic Heart Disease: Role of Exosomal MicroRNA Transfer , 2014, Circulation.

[50]  Christopher S. Chen,et al.  Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function. , 2014, The Journal of thoracic and cardiovascular surgery.

[51]  Andrés J. García,et al.  The modulation of cardiac progenitor cell function by hydrogel-dependent Notch1 activation. , 2014, Biomaterials.

[52]  D. C. Rodrigues,et al.  Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway , 2014, Stem Cell Research & Therapy.

[53]  R. Hullin.  Heart transplantation: current practice and outlook to the future. , 2014, Swiss medical weekly.

[54]  J. Mao,et al.  MicroRNA-23a is involved in tumor necrosis factor-α induced apoptosis in mesenchymal stem cells and myocardial infarction. , 2014, Experimental and molecular pathology.

[55]  M. Sever,et al.  Effects of Transendocardial CD34+ Cell Transplantation in Patients With Ischemic Cardiomyopathy , 2014, Circulation. Cardiovascular interventions.

[56]  H. Tse,et al.  Endomyocardial Implantation of Autologous Bone Marrow Mononuclear Cells in Advanced Ischemic Heart Failure: a Randomized Placebo-Controlled Trial (END-HF) , 2014, Journal of Cardiovascular Translational Research.

[57]  P. Serruys,et al.  Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial. , 2014, American heart journal.

[58]  G. Fortunato,et al.  Plasma-functionalized electrospun matrix for biograft development and cardiac function stabilization. , 2014, Acta biomaterialia.

[59]  W. Shim,et al.  iPSC-derived human mesenchymal stem cells improve myocardial strain of infarcted myocardium , 2014, Journal of cellular and molecular medicine.

[60]  M. Dikshit,et al.  Mesenchymal Stem Cells from Fetal Heart Attenuate Myocardial Injury after Infarction: An In Vivo Serial Pinhole Gated SPECT-CT Study in Rats , 2014, PloS one.

[61]  J. Sinisalo,et al.  Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: a prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[62]  Ali Ahmadi,et al.  The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardium. , 2014, Biomaterials.

[63]  Y. Ahn,et al.  Genistein Promotes Endothelial Colony-Forming Cell (ECFC) Bioactivities and Cardiac Regeneration in Myocardial Infarction , 2014, PloS one.

[64]  A. Zeiher,et al.  Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival. , 2014, European heart journal.

[65]  R. Bolli,et al.  c-kit+ Cardiac Stem Cells Alleviate Post-Myocardial Infarction Left Ventricular Dysfunction Despite Poor Engraftment and Negligible Retention in the Recipient Heart , 2014, PloS one.

[66]  Hai-bin Wang,et al.  The stem cell adjuvant with Exendin-4 repairs the heart after myocardial infarction via STAT3 activation , 2014, Journal of cellular and molecular medicine.

[67]  J. Kasprzak,et al.  In vitro and in vivo characteristics of connexin 43-modified human skeletal myoblasts as candidates for prospective stem cell therapy for the failing heart. , 2014, International journal of cardiology.

[68]  Katherine C. Wu,et al.  Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing Coronary Artery Bypass Grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Sur , 2014, Circulation research.

[69]  Shoei-Shen Wang,et al.  Injection of autologous bone marrow cells in hyaluronan hydrogel improves cardiac performance after infarction in pigs. , 2014, American journal of physiology. Heart and circulatory physiology.

[70]  R. Witte,et al.  An electrically coupled tissue-engineered cardiomyocyte scaffold improves cardiac function in rats with chronic heart failure. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[71]  J. Tijssen,et al.  Cell therapy in reperfused acute myocardial infarction does not improve the recovery of perfusion in the infarcted myocardium: a cardiac MR imaging study. , 2014, Radiology.

[72]  P. Bourin,et al.  Evaluation of polyelectrolyte complex-based scaffolds for mesenchymal stem cell therapy in cardiac ischemia treatment. , 2014, Acta biomaterialia.

[73]  S. Ohlmeier,et al.  Analysis of molecular changes after autologous cell therapy in swine myocardial infarction tissue can reveal novel targets for future therapy , 2014, Journal of tissue engineering and regenerative medicine.

[74]  M. Parmar,et al.  A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI) , 2014, BMJ Open.

[75]  Weiqian Chen,et al.  Timing of transplantation of autologous bone marrow derived mesenchymal stem cells for treating myocardial infarction , 2014, Science China Life Sciences.

[76]  V. Fuster,et al.  Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes , 2014, Stem Cell Research & Therapy.

[77]  P. Lesault,et al.  Nanotubular Crosstalk with Distressed Cardiomyocytes Stimulates the Paracrine Repair Function of Mesenchymal Stem Cells , 2014, Stem cells.

[78]  A. Bayés‐Genís,et al.  Allogeneic adipose stem cell therapy in acute myocardial infarction , 2014, European journal of clinical investigation.

[79]  J. Kastrup,et al.  Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina--final 3-year follow-up. , 2013, International journal of cardiology.

[80]  L. Ling,et al.  Grafts enriched with subamnion-cord-lining mesenchymal stem cell angiogenic spheroids induce post-ischemic myocardial revascularization and preserve cardiac function in failing rat hearts. , 2013, Stem cells and development.

[81]  M. Ward,et al.  eNOS overexpressing bone marrow cells are safe and effective in a porcine model of myocardial regeneration following acute myocardial infarction. , 2013, Cardiovascular therapeutics.

[82]  Hyun-Jai Cho,et al.  Phenotypic modulation of human cardiospheres between stemness and paracrine activity, and implications for combined transplantation in cardiovascular regeneration. , 2013, Biomaterials.

[83]  A. Chajut,et al.  Cardioprotection by placenta-derived stromal cells in a murine myocardial infarction model. , 2013, The Journal of surgical research.

[84]  B. Xiang,et al.  Assessment of three techniques for delivering stem cells to the heart using PET and MR imaging , 2013, EJNMMI Research.

[85]  Shengshou Hu,et al.  A pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction. , 2013, International journal of cardiology.

[86]  W. Cantor,et al.  Practice Patterns and Trends in the Use of Medical Therapy in Patients Undergoing Percutaneous Coronary Intervention in Ontario , 2013, Journal of the American Heart Association.

[87]  A. Hagège,et al.  Efficacy of epicardially delivered adipose stroma cell sheets in dilated cardiomyopathy. , 2013, Cardiovascular research.

[88]  W. Lu,et al.  mHCN4 Genetically Modified Canine Mesenchymal Stem Cells Provide Biological Pacemaking Function in Complete Dogs with Atrioventricular Block , 2013, Pacing and clinical electrophysiology : PACE.

[89]  Hao Fu,et al.  Improved mesenchymal stem cell survival in ischemic heart through electroacupuncture , 2013, Chinese Journal of Integrative Medicine.

[90]  Thomas E Sharp,et al.  Bone-Derived Stem Cells Repair the Heart After Myocardial Infarction Through Transdifferentiation and Paracrine Signaling Mechanisms , 2013, Circulation research.

[91]  A. Uchinaka,et al.  Transplantation of myoblast sheets that secrete the novel peptide SVVYGLR improves cardiac function in failing hearts. , 2013, Cardiovascular research.

[92]  P. Doevendans,et al.  Increasing short-term cardiomyocyte progenitor cell (CMPC) survival by necrostatin-1 did not further preserve cardiac function. , 2013, Cardiovascular research.

[93]  William Wijns,et al.  Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. , 2013, Journal of the American College of Cardiology.

[94]  A. Heldman,et al.  Durable Scar Size Reduction Due to Allogeneic Mesenchymal Stem Cell Therapy Regulates Whole‐Chamber Remodeling , 2013, Journal of the American Heart Association.

[95]  T. Henry,et al.  A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study. , 2013, American heart journal.

[96]  S. Houser,et al.  Prolyl Hydroxylase Domain Protein 2 Silencing Enhances the Survival and Paracrine Function of Transplanted Adipose-Derived Stem Cells in Infarcted Myocardium , 2013, Circulation research.

[97]  A. Erglis,et al.  Follow‐up of the patients after stem cell transplantation for pediatric dilated cardiomyopathy , 2013, Pediatric transplantation.

[98]  T. Couffinhal,et al.  Hypoxia-preconditioned mesenchymal stromal cells improve cardiac function in a swine model of chronic myocardial ischaemia. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[99]  S. Gronthos,et al.  Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction. , 2013, Journal of cardiac failure.

[100]  A. Zeiher,et al.  Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial. , 2013, JAMA.

[101]  Timothy J. Nelson,et al.  Induced pluripotent stem cell intervention rescues ventricular wall motion disparity, achieving biological cardiac resynchronization post-infarction , 2013, The Journal of physiology.

[102]  D. A. Gomes,et al.  Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction , 2013, Journal of cellular and molecular medicine.

[103]  L. Ye,et al.  Functional Consequences of Human Induced Pluripotent Stem Cell Therapy: Myocardial ATP Turnover Rate in the In Vivo Swine Heart With Postinfarction Remodeling , 2013, Circulation.

[104]  G. Pasterkamp,et al.  Feasibility of Intracoronary GLP-1 Eluting CellBead™ Infusion in Acute Myocardial Infarction , 2013, Cell transplantation.

[105]  Shoei-Shen Wang,et al.  Hyaluronan enhances bone marrow cell therapy for myocardial repair after infarction. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[106]  Mark A Sussman,et al.  Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After Myocardial Infarction , 2013, Circulation.

[107]  M. Sever,et al.  Effects of Intracoronary CD34+ Stem Cell Transplantation in Nonischemic Dilated Cardiomyopathy Patients: 5-Year Follow-Up , 2013, Circulation research.

[108]  S. Jalkanen,et al.  Nuclear imaging of inflammation: homing-associated molecules as targets , 2013, EJNMMI Research.

[109]  J. Connell,et al.  Effect of Cardiac Stem Cells on Left-Ventricular Remodeling in a Canine Model of Chronic Myocardial Infarction , 2013, Circulation. Heart failure.

[110]  D. Stewart,et al.  Human Blood and Cardiac Stem Cells Synergize to Enhance Cardiac Repair When Cotransplanted Into Ischemic Myocardium , 2012, Circulation.

[111]  S. Prakash,et al.  Functional Assessment of Adipose Stem Cells for Xenotransplantation Using Myocardial Infarction Immunocompetent Models: Comparison with Bone Marrow Stem Cells , 2011, Cell Biochemistry and Biophysics.

[112]  Yi Zhang,et al.  A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone , 2010, Nature Protocols.

[113]  Samuel Bernard,et al.  Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.

[114]  Bin Zhou,et al.  Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[115]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[116]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[117]  C. Frati.  Enhanced engraftment and repairing ability of human adipose-derived stem cells, conveyed by pharmacologically active microcarriers continuously releasing HGF and IGF-1, in healing myocardial infarction in rats , 2017 .

[118]  Jun Li,et al.  Nanoparticle-enhanced generation of gene-transfected mesenchymal stem cells for in vivo cardiac repair. , 2016, Biomaterials.

[119]  A. Rugowska,et al.  Human myoblast transplantation in mice infarcted heart alters the expression profile of cardiac genes associated with left ventricle remodeling. , 2016, International journal of cardiology.

[120]  D. Stewart,et al.  The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function. , 2014, Biomaterials.

[121]  Cheuk-Kwan Sun,et al.  Prompt bone marrow-derived mesenchymal stem cell therapy enables early porcine heart function recovery from acute myocardial infarction. , 2014, International heart journal.

[122]  H. Gulbins,et al.  Long-term follow-up after autologous skeletal myoblast transplantation in ischaemic heart disease. , 2014, Interactive cardiovascular and thoracic surgery.

[123]  M. Doblaré,et al.  Epicardial delivery of collagen patches with adipose-derived stem cells in rat and minipig models of chronic myocardial infarction. , 2014, Biomaterials.